Use of overnight metyrapone test in suspected secondary adrenal insufficiency: A retrospective single centre‐study
Saini J, Garcia R, Herndon J, Erickson D, Gruber L, Bancos I. Use of overnight metyrapone test in suspected secondary adrenal insufficiency: A retrospective single centre‐study. Clinical Endocrinology 2023, 100: 203-211. PMID: 37997487, PMCID: PMC10872941, DOI: 10.1111/cen.14989.Peer-Reviewed Original ResearchConceptsDiagnosis of secondary adrenal insufficiencyOvernight metyrapone testSecondary adrenal insufficiencyCosyntropin stimulation testAdverse eventsAdrenal insufficiencyMetyrapone testPretest probabilityRetrospective study of adult patientsSingle-centre retrospective studyRetrospective single center studyDevelopment of adverse eventsStudy of adult patientsSingle center studyModerate pretest probabilityAdult patientsStimulation testCenter studyPatientsInsufficiencyDiagnosisCosyntropinSAT300 Use of Overnight Metyrapone Test In Suspected Adrenal Insufficiency: A Retrospective Single Center-Study
Saini J, Garcia R, Herndon J, Erickson D, Gruber L, Bancos I. SAT300 Use of Overnight Metyrapone Test In Suspected Adrenal Insufficiency: A Retrospective Single Center-Study. Journal Of The Endocrine Society 2023, 7: bvad114.304. PMCID: PMC10554100, DOI: 10.1210/jendso/bvad114.304.Peer-Reviewed Original ResearchDiagnosis of secondary adrenal insufficiencyOvernight metyrapone testSecondary adrenal insufficiencyCosyntropin stimulation testPre-test probabilityAdrenal insufficiencyMetyrapone testSingle center retrospective studyRetrospective single center studyExogenous glucocorticoid useSuspected adrenal insufficiencyChronic opioid useSingle center studyEvaluation of symptomsOvernight metyraponeMedian doseGlucocorticoid useOpioid useRetrospective studyStimulation testAdverse eventsCenter studyCortisol suppressionPatientsRisk factors